Structure

Physi-Chem Properties

Molecular Weight:  526.15
Volume:  497.174
LogP:  2.923
LogD:  2.442
LogS:  -4.732
# Rotatable Bonds:  5
TPSA:  142.37
# H-Bond Aceptor:  11
# H-Bond Donor:  3
# Rings:  6
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.421
Synthetic Accessibility Score:  4.093
Fsp3:  0.37
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.784
MDCK Permeability:  3.6031757190357894e-05
Pgp-inhibitor:  0.1
Pgp-substrate:  0.434
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.036

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.101
Plasma Protein Binding (PPB):  84.09951782226562%
Volume Distribution (VD):  0.74
Pgp-substrate:  2.5438895225524902%

ADMET: Metabolism

CYP1A2-inhibitor:  0.35
CYP1A2-substrate:  0.902
CYP2C19-inhibitor:  0.315
CYP2C19-substrate:  0.194
CYP2C9-inhibitor:  0.366
CYP2C9-substrate:  0.889
CYP2D6-inhibitor:  0.666
CYP2D6-substrate:  0.846
CYP3A4-inhibitor:  0.778
CYP3A4-substrate:  0.112

ADMET: Excretion

Clearance (CL):  11.679
Half-life (T1/2):  0.293

ADMET: Toxicity

hERG Blockers:  0.172
Human Hepatotoxicity (H-HT):  0.154
Drug-inuced Liver Injury (DILI):  0.94
AMES Toxicity:  0.758
Rat Oral Acute Toxicity:  0.03
Maximum Recommended Daily Dose:  0.102
Skin Sensitization:  0.044
Carcinogencity:  0.923
Eye Corrosion:  0.003
Eye Irritation:  0.049
Respiratory Toxicity:  0.497

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC312006

Natural Product ID:  NPC312006
Common Name*:   Patentiflorin B
IUPAC Name:   9-(1,3-benzodioxol-5-yl)-6,7-dimethoxy-4-[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-3H-benzo[f][2]benzofuran-1-one
Synonyms:   patentiflorin B
Standard InCHIKey:  NLWUWPJUIJTHAN-HJTDAGSESA-N
Standard InCHI:  InChI=1S/C27H26O11/c1-11-22(28)23(29)24(30)27(37-11)38-25-14-8-18(33-3)17(32-2)7-13(14)20(21-15(25)9-34-26(21)31)12-4-5-16-19(6-12)36-10-35-16/h4-8,11,22-24,27-30H,9-10H2,1-3H3/t11-,22+,23+,24-,27+/m0/s1
SMILES:  COc1cc2c(O[C@H]3O[C@@H](C)[C@H]([C@H]([C@@H]3O)O)O)c3COC(=O)c3c(c2cc1OC)c1ccc2c(c1)OCO2
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL458905
PubChem CID:   11478022
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0001511] Lignan glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20590 Justicia patentiflora Species Acanthaceae Eukaryota n.a. Vietnamese n.a. PMID[15921419]
NPO20590 Justicia patentiflora Species Acanthaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 6.0 nM PMID[549446]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 300.0 nM PMID[549446]
NPT393 Cell Line HCT-116 Homo sapiens IC50 = 250.0 nM PMID[549446]
NPT393 Cell Line HCT-116 Homo sapiens IC50 > 10000.0 nM PMID[549447]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 1420.0 nM PMID[549447]
NPT91 Cell Line KB Homo sapiens IC50 > 10000.0 nM PMID[549447]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC312006 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC20114
1.0 High Similarity NPC471922
1.0 High Similarity NPC114550
1.0 High Similarity NPC471920
1.0 High Similarity NPC471921
1.0 High Similarity NPC474075
1.0 High Similarity NPC292712
1.0 High Similarity NPC129930
0.9756 High Similarity NPC35266
0.9697 High Similarity NPC161609
0.9697 High Similarity NPC275690
0.9693 High Similarity NPC184624
0.9634 High Similarity NPC193377
0.9627 High Similarity NPC471923
0.9568 High Similarity NPC475453
0.9568 High Similarity NPC473531
0.9524 High Similarity NPC167045
0.9524 High Similarity NPC114120
0.9412 High Similarity NPC313063
0.9412 High Similarity NPC286301
0.9394 High Similarity NPC473697
0.9333 High Similarity NPC52598
0.9321 High Similarity NPC116838
0.9321 High Similarity NPC22130
0.925 High Similarity NPC239113
0.925 High Similarity NPC115123
0.9157 High Similarity NPC117911
0.9152 High Similarity NPC474042
0.9152 High Similarity NPC174734
0.9091 High Similarity NPC222531
0.9085 High Similarity NPC198796
0.908 High Similarity NPC78944
0.9074 High Similarity NPC19600
0.9024 High Similarity NPC115624
0.9018 High Similarity NPC474043
0.9 High Similarity NPC196771
0.8994 High Similarity NPC316539
0.8957 High Similarity NPC143328
0.8953 High Similarity NPC208797
0.8953 High Similarity NPC53680
0.8909 High Similarity NPC152424
0.8909 High Similarity NPC15212
0.8909 High Similarity NPC100465
0.8889 High Similarity NPC79736
0.8889 High Similarity NPC67629
0.8882 High Similarity NPC474442
0.8882 High Similarity NPC199357
0.8876 High Similarity NPC135370
0.8875 High Similarity NPC475722
0.8869 High Similarity NPC79322
0.8855 High Similarity NPC22324
0.8837 High Similarity NPC47191
0.8837 High Similarity NPC267549
0.8834 High Similarity NPC234730
0.883 High Similarity NPC146803
0.8824 High Similarity NPC38438
0.8807 High Similarity NPC205721
0.8802 High Similarity NPC116759
0.8802 High Similarity NPC14294
0.8802 High Similarity NPC17432
0.878 High Similarity NPC109765
0.8773 High Similarity NPC54179
0.8757 High Similarity NPC298847
0.875 High Similarity NPC105591
0.875 High Similarity NPC178281
0.8735 High Similarity NPC96593
0.8735 High Similarity NPC119910
0.8727 High Similarity NPC202495
0.8727 High Similarity NPC19947
0.8727 High Similarity NPC207584
0.8715 High Similarity NPC476358
0.8698 High Similarity NPC306475
0.8698 High Similarity NPC83049
0.8698 High Similarity NPC118162
0.8698 High Similarity NPC320471
0.8696 High Similarity NPC127827
0.8683 High Similarity NPC258322
0.8683 High Similarity NPC288149
0.8683 High Similarity NPC191352
0.8678 High Similarity NPC212290
0.8675 High Similarity NPC125713
0.8671 High Similarity NPC297574
0.8667 High Similarity NPC32373
0.8667 High Similarity NPC237946
0.8667 High Similarity NPC473900
0.8655 High Similarity NPC298778
0.865 High Similarity NPC118332
0.8647 High Similarity NPC185498
0.8647 High Similarity NPC311912
0.8642 High Similarity NPC158635
0.8642 High Similarity NPC229882
0.8631 High Similarity NPC278329
0.8631 High Similarity NPC56735
0.8631 High Similarity NPC146837
0.8631 High Similarity NPC61594
0.8623 High Similarity NPC150943
0.8623 High Similarity NPC474770
0.8623 High Similarity NPC65784
0.8623 High Similarity NPC91634
0.8623 High Similarity NPC268718
0.8614 High Similarity NPC133984
0.8613 High Similarity NPC470667
0.8613 High Similarity NPC68381
0.8613 High Similarity NPC199533
0.8613 High Similarity NPC470454
0.8613 High Similarity NPC186800
0.8606 High Similarity NPC186316
0.8598 High Similarity NPC137813
0.8596 High Similarity NPC88557
0.8596 High Similarity NPC473202
0.8588 High Similarity NPC241847
0.858 High Similarity NPC111785
0.858 High Similarity NPC476203
0.858 High Similarity NPC121290
0.858 High Similarity NPC147596
0.8571 High Similarity NPC114257
0.8571 High Similarity NPC277710
0.8571 High Similarity NPC80956
0.8571 High Similarity NPC216916
0.8571 High Similarity NPC153578
0.8571 High Similarity NPC299149
0.8563 High Similarity NPC469397
0.8563 High Similarity NPC478269
0.8563 High Similarity NPC475054
0.8563 High Similarity NPC473713
0.8563 High Similarity NPC241600
0.8563 High Similarity NPC472723
0.8563 High Similarity NPC324220
0.8563 High Similarity NPC173726
0.8563 High Similarity NPC475233
0.8563 High Similarity NPC312630
0.8555 High Similarity NPC263119
0.8555 High Similarity NPC34436
0.8555 High Similarity NPC219600
0.8555 High Similarity NPC166674
0.8555 High Similarity NPC46640
0.8555 High Similarity NPC85368
0.8554 High Similarity NPC228357
0.8554 High Similarity NPC478055
0.8554 High Similarity NPC261090
0.8547 High Similarity NPC477572
0.8547 High Similarity NPC477571
0.8547 High Similarity NPC179240
0.8547 High Similarity NPC477573
0.8547 High Similarity NPC313304
0.8545 High Similarity NPC185103
0.8537 High Similarity NPC36130
0.8537 High Similarity NPC134905
0.8523 High Similarity NPC475161
0.8523 High Similarity NPC188217
0.8523 High Similarity NPC477860
0.8521 High Similarity NPC212099
0.8521 High Similarity NPC101116
0.8521 High Similarity NPC285108
0.8521 High Similarity NPC216752
0.8521 High Similarity NPC33298
0.8519 High Similarity NPC181464
0.8512 High Similarity NPC328093
0.8506 High Similarity NPC474345
0.8506 High Similarity NPC469438
0.8506 High Similarity NPC63105
0.8503 High Similarity NPC167098
0.8503 High Similarity NPC181168
0.8503 High Similarity NPC296044
0.8503 High Similarity NPC163527
0.8503 High Similarity NPC115281
0.85 High Similarity NPC264302
0.8497 Intermediate Similarity NPC111536
0.8497 Intermediate Similarity NPC5029
0.8497 Intermediate Similarity NPC76128
0.8497 Intermediate Similarity NPC271385
0.8497 Intermediate Similarity NPC30432
0.8494 Intermediate Similarity NPC10205
0.8494 Intermediate Similarity NPC472835
0.8488 Intermediate Similarity NPC259905
0.8488 Intermediate Similarity NPC191653
0.8485 Intermediate Similarity NPC61604
0.8485 Intermediate Similarity NPC299706
0.8485 Intermediate Similarity NPC115466
0.8485 Intermediate Similarity NPC245948
0.8485 Intermediate Similarity NPC245615
0.848 Intermediate Similarity NPC178851
0.8476 Intermediate Similarity NPC13985
0.8476 Intermediate Similarity NPC210642
0.8475 Intermediate Similarity NPC129533
0.8475 Intermediate Similarity NPC123259
0.8471 Intermediate Similarity NPC45943
0.8471 Intermediate Similarity NPC25889
0.8466 Intermediate Similarity NPC84494
0.8466 Intermediate Similarity NPC245059
0.8466 Intermediate Similarity NPC24193
0.8462 Intermediate Similarity NPC478267
0.8462 Intermediate Similarity NPC319749
0.8462 Intermediate Similarity NPC469889
0.8462 Intermediate Similarity NPC99968
0.8457 Intermediate Similarity NPC475246
0.8448 Intermediate Similarity NPC88560
0.8448 Intermediate Similarity NPC175230
0.8448 Intermediate Similarity NPC172033
0.8448 Intermediate Similarity NPC473550

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC312006 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8706 High Similarity NPD5844 Phase 1
0.8667 High Similarity NPD4967 Phase 2
0.8667 High Similarity NPD4965 Approved
0.8667 High Similarity NPD4966 Approved
0.8647 High Similarity NPD7228 Approved
0.8563 High Similarity NPD6234 Discontinued
0.8485 Intermediate Similarity NPD37 Approved
0.8462 Intermediate Similarity NPD7199 Phase 2
0.8448 Intermediate Similarity NPD6559 Discontinued
0.8448 Intermediate Similarity NPD7240 Approved
0.8352 Intermediate Similarity NPD8313 Approved
0.8352 Intermediate Similarity NPD8312 Approved
0.8323 Intermediate Similarity NPD8455 Phase 2
0.8304 Intermediate Similarity NPD6232 Discontinued
0.8256 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8225 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8222 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8218 Intermediate Similarity NPD3818 Discontinued
0.8161 Intermediate Similarity NPD7473 Discontinued
0.8125 Intermediate Similarity NPD7074 Phase 3
0.811 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.809 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8086 Intermediate Similarity NPD6674 Discontinued
0.8084 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.8068 Intermediate Similarity NPD7054 Approved
0.8056 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8033 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8023 Intermediate Similarity NPD7472 Approved
0.7964 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD6166 Phase 2
0.7895 Intermediate Similarity NPD1465 Phase 2
0.7889 Intermediate Similarity NPD7808 Phase 3
0.7877 Intermediate Similarity NPD6797 Phase 2
0.7874 Intermediate Similarity NPD5494 Approved
0.7861 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7844 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7833 Intermediate Similarity NPD7685 Pre-registration
0.7833 Intermediate Similarity NPD7251 Discontinued
0.7829 Intermediate Similarity NPD6959 Discontinued
0.7801 Intermediate Similarity NPD7680 Approved
0.7795 Intermediate Similarity NPD7783 Phase 2
0.7795 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD7819 Suspended
0.7791 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD3817 Phase 2
0.7733 Intermediate Similarity NPD1934 Approved
0.7727 Intermediate Similarity NPD8127 Discontinued
0.7711 Intermediate Similarity NPD4628 Phase 3
0.7692 Intermediate Similarity NPD8151 Discontinued
0.7661 Intermediate Similarity NPD3226 Approved
0.7636 Intermediate Similarity NPD2346 Discontinued
0.7617 Intermediate Similarity NPD7435 Discontinued
0.7602 Intermediate Similarity NPD1653 Approved
0.7588 Intermediate Similarity NPD6273 Approved
0.7586 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD3787 Discontinued
0.7572 Intermediate Similarity NPD7411 Suspended
0.7558 Intermediate Similarity NPD7458 Discontinued
0.7557 Intermediate Similarity NPD7075 Discontinued
0.7552 Intermediate Similarity NPD6777 Approved
0.7552 Intermediate Similarity NPD6780 Approved
0.7552 Intermediate Similarity NPD6776 Approved
0.7552 Intermediate Similarity NPD6778 Approved
0.7552 Intermediate Similarity NPD6779 Approved
0.7552 Intermediate Similarity NPD6782 Approved
0.7552 Intermediate Similarity NPD6781 Approved
0.7545 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD7266 Discontinued
0.7529 Intermediate Similarity NPD2533 Approved
0.7529 Intermediate Similarity NPD2534 Approved
0.7529 Intermediate Similarity NPD2532 Approved
0.7514 Intermediate Similarity NPD4380 Phase 2
0.7514 Intermediate Similarity NPD3751 Discontinued
0.7514 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3882 Suspended
0.75 Intermediate Similarity NPD7003 Approved
0.75 Intermediate Similarity NPD7768 Phase 2
0.7486 Intermediate Similarity NPD7229 Phase 3
0.7486 Intermediate Similarity NPD2801 Approved
0.7474 Intermediate Similarity NPD6823 Phase 2
0.7458 Intermediate Similarity NPD3749 Approved
0.7449 Intermediate Similarity NPD7999 Approved
0.7448 Intermediate Similarity NPD4420 Approved
0.7443 Intermediate Similarity NPD5402 Approved
0.7443 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD1933 Approved
0.7429 Intermediate Similarity NPD6801 Discontinued
0.7427 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7398 Intermediate Similarity NPD7870 Phase 2
0.7398 Intermediate Similarity NPD7871 Phase 2
0.7396 Intermediate Similarity NPD3750 Approved
0.7387 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7387 Intermediate Similarity NPD7874 Approved
0.7365 Intermediate Similarity NPD2438 Suspended
0.7362 Intermediate Similarity NPD6798 Discontinued
0.7347 Intermediate Similarity NPD7697 Approved
0.7347 Intermediate Similarity NPD7696 Phase 3
0.7347 Intermediate Similarity NPD7698 Approved
0.734 Intermediate Similarity NPD8150 Discontinued
0.7337 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7322 Intermediate Similarity NPD7177 Discontinued
0.7321 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7318 Intermediate Similarity NPD919 Approved
0.7314 Intermediate Similarity NPD6599 Discontinued
0.7314 Intermediate Similarity NPD7028 Phase 2
0.7305 Intermediate Similarity NPD3748 Approved
0.7296 Intermediate Similarity NPD5006 Approved
0.7296 Intermediate Similarity NPD5005 Approved
0.7292 Intermediate Similarity NPD6535 Approved
0.7292 Intermediate Similarity NPD6534 Approved
0.7286 Intermediate Similarity NPD7701 Phase 2
0.7262 Intermediate Similarity NPD5405 Approved
0.7262 Intermediate Similarity NPD5406 Approved
0.7262 Intermediate Similarity NPD5404 Approved
0.7262 Intermediate Similarity NPD2935 Discontinued
0.7262 Intermediate Similarity NPD5408 Approved
0.7258 Intermediate Similarity NPD7039 Approved
0.7258 Intermediate Similarity NPD7038 Approved
0.7256 Intermediate Similarity NPD3764 Approved
0.7253 Intermediate Similarity NPD3926 Phase 2
0.7249 Intermediate Similarity NPD8434 Phase 2
0.7246 Intermediate Similarity NPD7097 Phase 1
0.7241 Intermediate Similarity NPD7930 Approved
0.7241 Intermediate Similarity NPD5403 Approved
0.7229 Intermediate Similarity NPD6355 Discontinued
0.7229 Intermediate Similarity NPD447 Suspended
0.7225 Intermediate Similarity NPD5401 Approved
0.7222 Intermediate Similarity NPD8319 Approved
0.7222 Intermediate Similarity NPD8320 Phase 1
0.7212 Intermediate Similarity NPD6233 Phase 2
0.7205 Intermediate Similarity NPD1283 Approved
0.7202 Intermediate Similarity NPD2799 Discontinued
0.7195 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD4110 Phase 3
0.7179 Intermediate Similarity NPD7699 Phase 2
0.7179 Intermediate Similarity NPD7700 Phase 2
0.7178 Intermediate Similarity NPD7801 Approved
0.7169 Intermediate Similarity NPD4060 Phase 1
0.7169 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD2979 Phase 3
0.7169 Intermediate Similarity NPD1613 Approved
0.7168 Intermediate Similarity NPD6799 Approved
0.7168 Intermediate Similarity NPD1511 Approved
0.7152 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD6190 Approved
0.715 Intermediate Similarity NPD6213 Phase 3
0.715 Intermediate Similarity NPD6212 Phase 3
0.715 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1247 Approved
0.7129 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD3705 Approved
0.7118 Intermediate Similarity NPD5762 Approved
0.7118 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD6004 Phase 3
0.7118 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD6005 Phase 3
0.7118 Intermediate Similarity NPD5763 Approved
0.7118 Intermediate Similarity NPD6002 Phase 3
0.7115 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7104 Intermediate Similarity NPD5710 Approved
0.7104 Intermediate Similarity NPD5711 Approved
0.7093 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD1512 Approved
0.7076 Intermediate Similarity NPD2424 Discontinued
0.7048 Intermediate Similarity NPD2313 Discontinued
0.7048 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD920 Approved
0.7019 Intermediate Similarity NPD1281 Approved
0.7019 Intermediate Similarity NPD1091 Approved
0.7018 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD5058 Phase 3
0.7 Intermediate Similarity NPD5126 Approved
0.7 Intermediate Similarity NPD5125 Phase 3
0.7 Intermediate Similarity NPD4308 Phase 3
0.6988 Remote Similarity NPD4625 Phase 3
0.6988 Remote Similarity NPD3027 Phase 3
0.6983 Remote Similarity NPD7615 Clinical (unspecified phase)
0.698 Remote Similarity NPD7583 Approved
0.6977 Remote Similarity NPD1549 Phase 2
0.6977 Remote Similarity NPD970 Clinical (unspecified phase)
0.6971 Remote Similarity NPD7390 Discontinued
0.6964 Remote Similarity NPD4140 Approved
0.6959 Remote Similarity NPD4477 Approved
0.6959 Remote Similarity NPD4476 Approved
0.6959 Remote Similarity NPD1551 Phase 2
0.6959 Remote Similarity NPD2796 Approved
0.6952 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6952 Remote Similarity NPD7799 Discontinued
0.6951 Remote Similarity NPD2797 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data